NCT01441388: A Study Of Crizotinib Plus VEGF Inhibitor Combinations In Patients With Advanced Solid Tumors. |
|
|
| Withdrawn | 1b | 0 | US | Crizotinib plus VEGF inhibitor combinations, Crizotinib plus axitinib, Crizotinib plus sunitinib, Crizotinib plus bevacizumab, Crizotinib plus sorafenib | Pfizer | Carcinoma, Renal Cell, Glioblastoma, Carcinoma, Hepatocellular | 11/13 | 11/13 | | |
NCT00842244: Study Of Axitinib In Combination With Cisplatin And Capecitabine In Patients With Advanced Gastric Cancer |
|
|
| Completed | 1 | 22 | Japan, RoW | axitinib, capecitabine, cisplatin | Pfizer | Stomach Neoplasms, Advanced Gastric Cancer | 12/09 | 10/12 | | |